| PUBCHEM ID |
56841981
|
| UNII |
P9VXV1408Y
|
| Preferred Term |
CEFTAROLINE FOSAMIL ACETATE
|
| CAS |
400827-55-6
|
| INCHIKEY |
KRWPPVCZNGQQHZ-IINIBMQSSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CCO/N=C(\C(N[C@H]([C@@H]1SCC(Sc2nc(-c3ccn(C)cc3)cs2)=C(C(O)=O)N11)C1=O)=O)/c1nsc(NP(O)(O)=O)n1
|
| Total Surface Area |
452,55
|
| Relative PSA |
0,57209
|
| TPSA |
338,35
|
| cLogS |
-2,237
|
| MW |
685,703
|
| cLogP |
-1,6031
|
| H-Acceptors |
16
|
| H-Donors |
5
|
| Ro5 violations |
2
|
| Druglikeness |
3,4603
|
| DrugScore |
0,419094220120996
|
| Mutagenic |
low
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
-0,4875
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,3046
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,6107
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,5462
|
| Carcinogenicity (Three-class) |
Non-required
|
